The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 12, 2022
Filed:
Sep. 30, 2018
Applicant:
Shenzhen Targetrx, Inc., Guangdong, CN;
Inventors:
Yihan Wang, Guangdong, CN;
Huanyin Li, Guangdong, CN;
Assignee:
Shenzhen TargetRx, Inc., Guangdong, CN;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 403/12 (2006.01); C07D 239/48 (2006.01); A61P 17/06 (2006.01); A61P 27/02 (2006.01); A61P 25/16 (2006.01); A61P 25/28 (2006.01); A61P 29/00 (2006.01); A61P 19/08 (2006.01); A61P 35/00 (2006.01); A61P 35/02 (2006.01); A61P 1/16 (2006.01); A61P 31/12 (2006.01); A61P 3/10 (2006.01); A61P 21/04 (2006.01); A61P 37/06 (2006.01); A61P 7/02 (2006.01); A61P 9/00 (2006.01); A61P 9/10 (2006.01); A61P 11/06 (2006.01);
U.S. Cl.
CPC ...
C07D 403/12 (2013.01); C07B 2200/05 (2013.01);
Abstract
Provided in the present invention are a pharmaceutical composition of a substituted diphenylaminopyrimidine compound and a use thereof, wherein the compound is the compound as shown in formula (I), or a pharmaceutically acceptable salt, prodrug, hydrate or solvate, crystal form, N-oxide and various diastereomers thereof. The compound of the present invention can be used for treating diseases that can be treated with the JAK2 kinase inhibitor.